Martha Morrell - 24 Jun 2026 Form 4 Insider Report for NeuroPace Inc (NPCE)

Reporting relationship: CHIEF MEDICAL OFFICER
Issuer ticker: NPCE
Reported as of: 24 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 25 Jun 2026, 16:12:02 UTC
Prior SEC filing: 28 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Leah Akin, Attorney-in-Fact

Key filing fact

Martha Morrell filed Form 4 for NeuroPace Inc (NPCE) on 25 Jun 2026.

Key facts

This page summarizes Martha Morrell's Form 4 filing for NeuroPace Inc (NPCE).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 25 Jun 2026, 16:12.

Change

Previous filing in this sequence was filed on 28 May 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001855616 Primary reporting owner

Morrell Martha

Relationship: CHIEF MEDICAL OFFICER
Address: C/O NEUROPACE INC., 455 N. BERNARDO AVENUE, MOUNTAIN VIEW
Signature: /s/ Leah Akin, Attorney-in-Fact
Signature date: 25 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NPCE transaction

Common Stock

Tax liability

Transaction value
Shares: -335
Change %: -0.64%
Price: $16.22^*
Shares after: 52,050
Date: 24 Jun 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents the number of shares withheld by the Issuer on June 24, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award.